 Flecainide treatment paroxysmal supraventricular tachycardia paroxysmal atrial fibrillation dose-response studies Flecainide Supraventricular Tachycardia Study Group dose-response relations efficacy tolerance antiarrhythmic drug flecainide acetate patients paroxysmal supraventricular tachycardia Group patients paroxysmal atrial fibrillation flutter Group Recurrent symptomatic tachycardia use transtelephonic electrocardiographic recording Patients doses mg month treatment periods patients Group efficacy analysis tachycardia placebo number tachycardia flecainide doses mg patients tachycardia overall differences treatments patients Group tachycardia placebo number tachycardia flecainide doses mg patients tachycardia overall differences treatments Noncardiac adverse experiences cause premature study discontinuation flecainide treatment periods patients Group patients Group